The AFL’s new radio rights agreement is a far cry from the $4.5 billion, seven-year broadcast deal, with the prospect of losing Triple M proving...

The AFL’s new radio rights agreement is a far cry from the $4.5 billion, seven-year broadcast deal, with the prospect of losing Triple M proving...

The AFL’s new radio rights agreement is a far cry from the $4.5 billion, seven-year broadcast deal, with the prospect of losing Triple M proving...

Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in...

DNN enters into an agreement with Foremost Lithium, which grants the latter an opportunity to buy up to 70% of the non-core projects.

Ventyx stock climbs 7% on signing a $27 million strategic investment agreement with Sanofi in exchange for granting exclusive rights to VTX3232.

In the latest trading session, Merck (MRK) closed at $113.09, marking a -1.43% move from the previous day.

Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on...

Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on...

Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on...